Sight Sciences SGHT
NASDAQ SGHT
$8.26 +0.11 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Sight Sciences (SGHT) Preferred Stock Liabilities (2020 - 2021)

Sight Sciences (SGHT) posted quarterly Preferred Stock Liabilities of $117.3 million for Q2 2021, little changed quarter-over-quarter from $117.3 million in Q1 2021.

Sight Sciences (SGHT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

Sight Sciences' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $117.3 million for Q2 2021.

  • In Q2 2021, Preferred Stock Liabilities changed N/A year-over-year to $117.3 million; the TTM figure through Jun 2021 stood at $117.3 million (changed N/A YoY), while the FY2020 annual figure was $117.3 million, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q2 2021 stood at $117.3 million, roughly flat from $117.3 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $117.3 million in Q4 2020, with the low at $94.2 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Sight Sciences 449.13 Mn 369.37 Mn 21.37 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 117.33 Mn
Mar 31, 2021 117.33 Mn
Dec 31, 2020 117.33 Mn
Sep 30, 2020 94.24 Mn